The epidemiology of glioma in adults: a "state of the science" review.
Explore this paper's citation graph
Summary
A “state of the science” review of current research into causes and risk factors for gliomas in adults is provided.
- Type
- review
- Published
- 2014-07-01
- Cited by
- 2,025
- References
- 168
- Access
- Open access
- OpenAlex
- https://openalex.org/W2135465849
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:29689803
Keywords
Glioma, Oncology, Medicine, Internal medicine, DNA methylation
References
- Cancer Mortality in a Cohort of Male Agricultural Workers From Northern Italy
- CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.
- Occupation and the risk of adult glioma in the United States
- Environmental Health Criteria 238: EXTREMELY LOW FREQUENCY FIELDS
- Conditional probability of long‐term survival in glioblastoma
- Interaction of allergy history and antibodies to specific Varicella zoster virus proteins on glioma risk
- Primary brain tumours and specific serum immunoglobulin E: a case–control study nested in the European Prospective Investigation into Cancer and Nutrition cohort
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- Interactive effect of chemical substances and occupational electromagnetic field exposure on the risk of gliomas and meningiomas in Swedish men.
- Occupational risks for intracranial gliomas in Sweden.
- Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study.
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- Occupational Risk Factors for Brain Cancer: A Population-Based Case-Control Study in Iowa
- Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors
- Epidemiology: allergy history, IgE, and cancer
- Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
- Primary brain tumour epidemiology in Georgia: first-year results of a population-based study
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- Case-cohort analysis of brain cancer and leukemia in electric utility workers using a refined magnetic field job-exposure matrix.
Cited by
- How Treatment Monitoring Is Influencing Treatment Decisions in Glioblastomas
- High-grade Gliomas
- Immunotherapy for brain tumors: understanding early successes and limitations
- Epidemiology of gliomas.
- Glioma: an overview of current classifications, characteristics, molecular biology and target therapies.
- Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
- Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
- MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
- microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression.
- Predictive biomarkers in diffuse gliomas and non-small cell lung cancer
- Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time
- Input of molecular analysis in medical management of primary brain tumor patients.
- Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma
- Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.
- Fluorescence guided resection and glioblastoma in 2015: A review
- Case-Based Review: newly diagnosed glioblastoma.
- Telomere maintenance and the etiology of adult glioma.
- Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2 amplified and TP53 wild-type glioblastomas
- Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes
- The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells.
Related papers
- Expression and functional implications of USP17 in glioma.
- LncRNA LINC01094 contributes to glioma progression by modulating miR-224-5p/CHSY1 axis
- MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2.
- CPLX2 is a novel tumor suppressor and improves the prognosis in glioma
- Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.
- CircRFX3 Up-regulates Its Host Gene RFX3 to Facilitate Tumorigenesis and Progression of Glioma
- A dynamical model of combination therapy applied to glioma
- The expression and clinical significance of the MMP-2 and MMP-9 in human glioma and glioma's invasive tissue
- Prognostic Potential of METTL7B in Glioma